Pulished Date October, 2018
ID: 143
Share on
Share on

The Nuclear Medicine Diagnostics Market is predicted to reach $ 18.27 billion USD with a CAGR of 13.2% according to Market Data Forecast report.

Pulished: October, 2018
ID: 143
Pages: 0

The Nuclear Medicine Diagnostics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape etc. According to the report the Nuclear Medicine Diagnostics Market is estimated to be $9.83 billion USD and predicted to rise to $ 18.27 billion USD with a CAGR of 13.2%. The market is segmented by SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others), PET (Rubidium-82 (RB-82), Fluorine-18, and others), and applications SPECT (lymphoma, cardiology, neurology, thyroid and others) and PET (cardiology, oncology, neurology and others). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa

Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are the major factors driving the growth of the market. However, short half-life of radio isotopes, stringent regulatory guidelines and reimbursement issues are the major restraints for the growth of nuclear medicine diagnostics market.

North America is the largest market for Nuclear Medicine Diagnostics Market owing to the increasing preference for SPECT and PET scans. Asia-Pacific is estimated to be the fastest growing market due to increasing count of individuals suffering from with cancer and cardiac ailments during the forecast period.

The major companies covered in the report are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/” and checkout our recent reports in the Diagnostics category at “http://www.marketdataforecast.com/research-reports/healthcare/diagnostics-5/”. For more insights and up-to-date industry news doesn’t forget subscribing to our newsletters.

LICENCE TYPE

$ 1234 0

Clients
clients
clients
clients
clients
clients
clients

Research Areas